Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited) - USD ($) $ in Thousands	Total	ZeroFox, Inc. [Member]	Series E Redeemable Convertible Preferred Stock [Member]	Series E Redeemable Convertible Preferred Stock [Member] ZeroFox, Inc. [Member]	Series D-2 Redeemable Convertible Preferred Stock [Member]	Series D-2 Redeemable Convertible Preferred Stock [Member] ZeroFox, Inc. [Member]	Series D-1 Redeemable Convertible Preferred Stock [Member]	Series D-1 Redeemable Convertible Preferred Stock [Member] ZeroFox, Inc. [Member]	Series D Redeemable Convertible Preferred Stock [Member]	Series D Redeemable Convertible Preferred Stock [Member] ZeroFox, Inc. [Member]	Series C-1 Redeemable Convertible Preferred Stock [Member]	Series C-1 Redeemable Convertible Preferred Stock [Member] ZeroFox, Inc. [Member]	Series C Redeemable Convertible Preferred Stock [Member]	Series C Redeemable Convertible Preferred Stock [Member] ZeroFox, Inc. [Member]	Series B Redeemable Convertible Preferred Stock [Member]	Series B Redeemable Convertible Preferred Stock [Member] ZeroFox, Inc. [Member]	Series A Redeemable Convertible Preferred Stock [Member]	Series A Redeemable Convertible Preferred Stock [Member] ZeroFox, Inc. [Member]	Series Seed Redeemable Convertible Preferred Stock [Member]	Series Seed Redeemable Convertible Preferred Stock [Member] ZeroFox, Inc. [Member]	Redeemable Convertible Preferred Stock [Member]	Redeemable Convertible Preferred Stock [Member] ZeroFox, Inc. [Member]	Common Stock [Member]	Common Stock [Member] ZeroFox, Inc. [Member]	Additional Paid-in Capital [Member]	Additional Paid-in Capital [Member] ZeroFox, Inc. [Member]	Accumulated Deficit [Member]	Accumulated Deficit [Member] ZeroFox, Inc. [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Accumulated Other Comprehensive Income (Loss) [Member] ZeroFox, Inc. [Member]
Beginning balance at Jan. 31, 2022				$ 33,248		$ 1,451		$ 8,171		$ 21,067		$ 13,979		$ 19,899		$ 22,047		$ 10,159		$ 2,208		$ 132,229
Beginning balance (in shares) at Jan. 31, 2022				15,227,437		993,868		5,878,303		13,871,547		11,376,115		21,124,699		26,914,949		15,997,285		9,198,372		120,582,575
Beginning balance at Jan. 31, 2022		$ (153,148)																								$ 3,873		$ (156,820)		$ (201)
Beginning balance (in shares) at Jan. 31, 2022																								42,892,927
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of warrants				$ 3,043								$ 2,857										$ 5,900
Exercise of warrants (in shares)				539,576								506,490										1,046,066
Stock-based compensation expense		852																								852
Exercise of options		104																								104
Exercise of options (in shares)	392,450																							392,074
Net loss	$ (21,458)	(21,458)																										(21,458)
Foreign currency translation adjustment		42																												42
Ending balance at Jul. 31, 2022			$ 36,291	$ 36,291	$ 1,451	$ 1,451	$ 8,171	$ 8,171	$ 21,067	$ 21,067	$ 16,836	$ 16,836	$ 19,899	$ 19,899	$ 22,047	$ 22,047	$ 10,159	$ 10,159	$ 2,208	$ 2,208	$ 138,129	$ 138,129
Ending balance (in shares) at Jul. 31, 2022			15,767,013	15,767,013	993,868	993,868	5,878,303	5,878,303	13,871,547	13,871,547	11,882,605	11,882,605	21,124,699	21,124,699	26,914,949	26,914,949	15,997,285	15,997,285	9,198,372	9,198,372	121,628,641	121,628,641
Ending balance at Jul. 31, 2022		(173,608)																								4,829		(178,278)		(159)
Ending balance (in shares) at Jul. 31, 2022																								43,285,001
Beginning balance at Apr. 30, 2022				$ 33,248		$ 1,451		$ 8,171		$ 21,067		$ 13,979		$ 19,899		$ 22,047		$ 10,159		$ 2,208		$ 132,229
Beginning balance (in shares) at Apr. 30, 2022				15,227,437		993,868		5,878,303		13,871,547		11,376,115		21,124,699		26,914,949		15,997,285		9,198,372		120,582,575
Beginning balance at Apr. 30, 2022		(162,843)																								4,327		(167,023)		(147)
Beginning balance (in shares) at Apr. 30, 2022																								43,207,753
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of warrants				$ 3,043								$ 2,857										$ 5,900
Exercise of warrants (in shares)				539,576								506,490										1,046,066
Stock-based compensation expense		478																								478
Exercise of options		24																								24
Exercise of options (in shares)																								77,248
Net loss	(11,255)	(11,255)																										(11,255)
Foreign currency translation adjustment		(12)																												(12)
Ending balance at Jul. 31, 2022			$ 36,291	$ 36,291	$ 1,451	$ 1,451	$ 8,171	$ 8,171	$ 21,067	$ 21,067	$ 16,836	$ 16,836	$ 19,899	$ 19,899	$ 22,047	$ 22,047	$ 10,159	$ 10,159	$ 2,208	$ 2,208	$ 138,129	$ 138,129
Ending balance (in shares) at Jul. 31, 2022			15,767,013	15,767,013	993,868	993,868	5,878,303	5,878,303	13,871,547	13,871,547	11,882,605	11,882,605	21,124,699	21,124,699	26,914,949	26,914,949	15,997,285	15,997,285	9,198,372	9,198,372	121,628,641	121,628,641
Ending balance at Jul. 31, 2022		$ (173,608)																								$ 4,829		$ (178,278)		$ (159)
Ending balance (in shares) at Jul. 31, 2022																								43,285,001
Beginning balance at Jan. 31, 2023	488,871																						$ 12		$ 1,243,637		$ (754,677)		$ (101)
Beginning balance (in shares) at Jan. 31, 2023																							118,190,135
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	3,413																								3,413
Exercise of options	$ 262																								262
Exercise of options (in shares)	762,153																						762,153
Vesting of restricted stock units (in shares)																							317,926
Other	$ 2,836																								2,836
Net loss	(34,815)																										(34,815)
Foreign currency translation adjustment	133																												133
Ending balance at Jul. 31, 2023	460,700																						$ 12		1,250,148		(789,492)		32
Ending balance (in shares) at Jul. 31, 2023																							119,270,214
Beginning balance at Apr. 30, 2023	474,932																						$ 12		1,247,652		(772,656)		(76)
Beginning balance (in shares) at Apr. 30, 2023																							118,663,481
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	2,314																								2,314
Exercise of options	182																								182
Exercise of options (in shares)																							288,807
Vesting of restricted stock units (in shares)																							317,926
Net loss	(16,836)																										(16,836)
Foreign currency translation adjustment	108																												108
Ending balance at Jul. 31, 2023	$ 460,700																						$ 12		$ 1,250,148		$ (789,492)		$ 32
Ending balance (in shares) at Jul. 31, 2023																							119,270,214